Evidence map›Paper›PMID 40339609›Full record

ReviewThe Journal of allergy and clinical immunology2025

Eosinophilic esophagitis: An allergy and immunology perspective on the updated guidelines.

Emily C McGowan, Benjamin L Wright, Melanie A Ruffner, Robert D Pesek, Marc E Rothenberg, Jonathan M Spergel, Evan S Dellon, Seema S Aceves

Abstract readReview
In one paragraph

Review in The Journal of allergy and clinical immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Emily C McGowanDepartments of Medicine and Pediatrics, Division of Allergy and Immunology, University of Virginia School of Medicine, Charlottesville, Va.
Benjamin L WrightDepartment of Medicine, Division of Allergy, Asthma, and Clinical Immunology, Mayo Clinic, Phoenix, Ariz; Division of Allergy and Immunology, Phoenix Children's Hospital, Phoenix, Ariz.
Melanie A RuffnerDepartment of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pa; Department of Pediatrics, Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pa.
Robert D PesekDepartment of Pediatrics, Division of Allergy and Immunology, University of Arkansas for Medical Sciences, Little Rock, Ark; Arkansas Children's Hospital, Little Rock, Ark.
Marc E RothenbergDepartment of Pediatrics, Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, and the University of Cincinnati College of Medicine, Cincinnati, Ohio.
Jonathan M SpergelDepartment of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pa; Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pa.
Evan S DellonDivision of Gastroenterology and Hepatology, Center for Esophageal Diseases and Swallowing, and Center for Gastrointestinal Biology and Disease, University of North Carolina School of Medicine, Chapel Hill, NC.
Seema S AcevesDepartment of Pediatrics and Medicine, Division of Allergy, Immunology, University of California, San Diego and Rady Children's Health, San Diego, Calif. Electronic address: saceves@health.ucsd.edu.

Funding

The Impact of COVID-19 on People Living with Rare Diseases and Their FamiliesU2CTR002818 · NCATS · CINCINNATI CHILDRENS HOSP MED CTR · PI Michal Kouril · 2019 to 2026
$51.2M
TSLP, IL-9-producing mucosal mast cells, and allergic inflammationU19AI070235 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI Marc E. Rothenberg · 2006 to 2026
$31.3M
TRAINING (CAREER DEVELOPMENT) COMPONENTU54AI117804 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI Nirmala P Gonsalves · 2014 to 2026
$18.5M
Genetic and Immunological Dissection of Eosinophilic EsophagitisR01AI124355 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI Marc E. Rothenberg · 2015 to 2026
$5.9M
REGULATION OF GASTROINTESTINAL EOSINOPHILSR01AI045898 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI ROTHENBERG, MARC E. · 1999 to 2024
$4.5M
Defining the Role of Immunoglobulin G4 (IgG4) in Food-Induced Eosinophilic Esophagitis (EoE)R01AI175232 · NIAID · UNIVERSITY OF VIRGINIA · PI Emily Clarke McGowan · 2023 to 2026
$3.1M
NCATS NIH HHS U2C TR002818NIAID NIH HHS R01 AI045898NIAID NIH HHS R01 AI124355NIAID NIH HHS R01 AI175232NIAID NIH HHS U19 AI070235NIAID NIH HHS U54 AI117804
6 · The paper itself

Abstract

In January 2025, the American College of Gastroenterology published updated guidelines on the diagnosis and management of eosinophilic esophagitis (EoE). These new guidelines incorporated updated information on the pathophysiology, risk factors, natural history, and treatment of EoE. These guidelines were primarily intended for practicing gastroenterologists; therefore, we summarize their key recommendations for the allergy and immunology community. In addition, as the prevalence and health care burden of EoE continues to increase, the population affected primarily comprises allergic individuals, and less invasive monitoring techniques are on the horizon, we discuss the key means by which allergists can contribute to the diagnosis and management of EoE. In particular, allergists can participate in screening for subtle EoE symptoms among their allergy patients, assist in optimizing the management of other allergic comorbidities, provide education about elimination diets, and facilitate the monitoring of disease over time. Allergists are uniquely poised to treat the entire allergic individual, rather than just the allergic esophagus, and should be prepared to co-manage these patients along with gastroenterologists.

Indexed as

Eosinophilic EsophagitisAllergy and ImmunologyHumansHypersensitivityPractice Guidelines as TopicallergyEosinophilic esophagitisfibrosisguidelinesinflammatoryskin testing

Identifiers

PMID40339609
PMCPMC12873651

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.